CPT 88121Laboratory

Cytp urine 3-5 probes cmptr

CPT code 88121 is for a specialized urine test that examines cells under a microscope and uses 3-5 DNA probes analyzed by computer to detect abnormalities, particularly for bladder cancer screening or monitoring.

Showing rates for

National Average

Base Medicare rate

$393.33

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

PE RVU (NF)

11.12

MP RVU

0.04

Total RVU

12.16

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Verify exact probe count documentation - 88121 requires 3-5 probes; if 6+ probes are used, code 88120 may be more appropriate and reimburses higher
Impact: Incorrect probe count documentation can result in denial or downgrade to 88108 (non-automated screening) at approximately $66-$112, losing over $280 in reimbursement
Document computer-assisted analysis explicitly - the pathology report must specify automated fluorescence microscopy or computer enumeration of signals
Impact: Missing computer analysis documentation may trigger downcode to manual fluorescence methods, potentially reducing payment by 30-40%
Bill global code (88121) when laboratory performs both technical and professional components; split with 26/TC only when services span multiple entities
Impact: Unnecessary modifier use can delay payment by 15-30 days and trigger manual review; global billing ensures full $393.33 payment in single claim
Check for local coverage determinations (LCDs) - some Medicare contractors require specific ICD-10 codes (C67.x, D09.0, R31.x, Z85.51) for coverage
Impact: Non-covered diagnosis codes result in 100% denial; preauthorization may be required for surveillance testing beyond specific intervals
Do not unbundle 88121 from surgical pathology codes when specimen is obtained during cystoscopy - bill only the surgical pathology code if tissue and urine are from same encounter
Impact: Unbundling violations can result in full recoupment of $393.33 plus potential fraud investigation and up to 3x penalties
Maintain FISH probe lot documentation, validation studies, and quality control records for minimum 2 years to support medical necessity during audits

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88121?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT 88121 in 2025?

The 2025 Medicare national average payment for CPT 88121 is $393.33 for both facility and non-facility settings. This rate is based on 12.16 total RVUs multiplied by the 2025 conversion factor of $32.3465. Local rates may vary slightly based on geographic practice cost indices (GPCI).

How many DNA probes are required for CPT code 88121?

CPT 88121 specifically requires 3-5 DNA probes with computer-assisted analysis. If 6 or more probes are used, CPT 88120 should be billed instead. If fewer than 3 probes are used, the service may need to be reported with a different cytopathology code. The most common application uses 4 probes (UroVysion FISH test).

Can CPT 88121 be billed with conventional urine cytology on the same specimen?

Yes, CPT 88121 (FISH) and conventional urine cytology (88112-88108) can be billed together as they represent distinct methodologies with complementary diagnostic value. However, modifier 59 may be required to indicate distinct procedural services, and medical necessity for both tests must be clearly documented. Some payers have specific coverage policies limiting combined testing.

What diagnosis codes support medical necessity for CPT 88121?

Commonly covered ICD-10 codes include C67.x (malignant neoplasm of bladder), Z85.51 (personal history of bladder cancer), D09.0 (carcinoma in situ of bladder), R31.x (hematuria), and D41.4 (neoplasm of uncertain behavior of bladder). Non-specific screening codes without documented risk factors are typically denied. Always verify local coverage determinations (LCDs) for your MAC jurisdiction.

How often can CPT 88121 be billed for bladder cancer surveillance?

Frequency limitations vary by Medicare contractor, but typical LCDs allow surveillance testing every 3-6 months for patients with history of bladder cancer. More frequent testing requires documentation of new symptoms, suspicious cystoscopy findings, or progression. Commercial payers may have different policies. Modifier 91 may be needed for same-day repeat testing with documented medical necessity.

What is the difference between CPT 88120 and 88121?

The primary difference is probe count: CPT 88121 covers 3-5 DNA probes while CPT 88120 covers 6 or more probes. Both require computer-assisted analysis. CPT 88120 typically reimburses at a higher rate due to increased technical complexity. Accurate probe count documentation is critical to prevent coding errors and audit exposure.

Do I need a CLIA certificate to bill CPT 88121?

Yes, CPT 88121 is categorized as high-complexity testing under CLIA and requires a high-complexity CLIA certificate. The laboratory must have appropriate personnel qualifications (board-certified pathologist supervision), validated procedures, and quality control programs. CAP or equivalent accreditation is typically required for molecular cytogenetic testing. Non-compliance can result in claim denials and regulatory sanctions.